Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher, Immundiagnostik to Co-develop Mass Spec-based Assays

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific and German diagnostics firm Immundiagnostik said today they are partnering to develop mass spectrometry-based assays for the qualitative and quantitative analysis of proteins and peptides.

A number of Thermo Fisher's liquid chromatography-triple quadrupole mass spectrometry systems will be used as part of the deal, including the firm's high-throughput Mass Spectrometric Immunoassay technology, its TSQ Vantage Triple Quadrupole mass spec for the quantitative analysis of small peptides, and the Orbitrap Elite instrument for measuring post-translational modifications.

The technologies will be combined with Immundiagnostik's ImmunoTube antibody technology for optimizing sample preparation and isolating low-level analytes to create new assays for diagnosing cardiovascular diseases and bone metabolism disorders, the partners said. The assays are being developed to selectively identify all molecular variations of peptides and proteins, with the ultimate goal of developing commercial assays for research use as well as for routine clinical analysis.

Immundiagnostik is providing a venue for demonstrating various Thermo Fisher technology applications as part of the deal, and will use its academic and clinical network to identify diagnostic parameters, validate novel LC-MS/MS products, and develop new assays for commercial launches.

Financial and other terms of the deal were not disclosed.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.